Sleep Series This is the 2nd in a series of (at least) 4 blogs on sleep. Health Rising’s Sleep Series Pt. I – Dr. Bruck Interview – Bronc kicked the series off with an interview of Dr. Bruck – a retired sleep researcher whose son has ME/CFS. Pt. II...
If Tonix doesn’t get FDA approval for their new fibromyalgia (FM) drug, it won’t be for lack of trying. The small drug manufacturer’s flagship product, TNX-102 SL, has had more ups and downs than a rollercoaster. It’s been pretty much given up...
Clinical Trials Ending This Year or Late Last Year The coronavirus pandemic stopped everything for quite a while but the clinical trials which survived the pandemic probably started up again quite some time ago. All we have to go by, though, are the stated completion...
Still at the Beginning? A recent review “Current and Emerging Pharmacotherapy for Fibromyalgia” examined the state of drug therapy for FM. It was a bluntly honest review. The news on the drug side has not been, after all, all that good in FM. A large study...
Both fibromyalgia (FM) and chronic fatigue syndrome (ME/CFS) clearly need better treatments. The FDA-approved drugs for these diseases are too often ineffective, come with too many side effects (fibromyalgia) or just aren’t available at all (ME/CFS). Too many...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.